Shares of VolitionRx Ltd. (VNRX) are soaring over 80% in pre-market today, after the company announced that results from two proof of concept clinical studies using its Nu.Q assays have been submitted for peer review and would be available on BIORXIV.ORG shortly.
from RTT - Before the Bell https://ift.tt/30dbDsq
via IFTTT
No comments:
Post a Comment